Loading the security overview…
Where the tokens are
What Ionis Pharmaceuticals has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Sep 23, 2026 | 8-K | Current report | On SEC.gov |
| Sep 4, 2026 | 8-K | Current report | On SEC.gov |
| Sep 4, 2026 | 8-K | Current report | On SEC.gov |
| Jul 29, 2026 | 8-K | Current report | On SEC.gov |
| Jul 29, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Jul 10, 2026 | 8-K | Current report | On SEC.gov |
| Jul 9, 2026 | 8-K | Current report | On SEC.gov |
| Jun 24, 2026 | 8-K | Current report | On SEC.gov |
| Jun 12, 2026 | 8-K | Current report | On SEC.gov |
| Jun 8, 2026 | 8-K | Current report | On SEC.gov |
| May 28, 2026 | 8-K | Current report | On SEC.gov |
| Apr 29, 2026 | 8-K | Current report | On SEC.gov |
| Apr 29, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Apr 21, 2026 | 8-K | Current report | On SEC.gov |
| Mar 9, 2026 | 8-K | Current report | On SEC.gov |
| Feb 26, 2026 | 10-K | Annual report | On SEC.gov |
| Feb 25, 2026 | 8-K | Current report | On SEC.gov |
| Jan 12, 2026 | 8-K | Current report | On SEC.gov |
| Jan 7, 2026 | 8-K | Current report | On SEC.gov |
| Nov 17, 2025 | 8-K | Current report | On SEC.gov |
| Nov 10, 2025 | 8-K | Current report | On SEC.gov |
| Oct 29, 2025 | 8-K | Current report | On SEC.gov |
| Oct 29, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Sep 22, 2025 | 8-K | Current report | On SEC.gov |
| Sep 2, 2025 | 8-K | Current report | On SEC.gov |
| Aug 21, 2025 | 8-K | Current report | On SEC.gov |
| Jul 30, 2025 | 8-K | Current report | On SEC.gov |
| Jul 30, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Jun 12, 2025 | 8-K | Current report | On SEC.gov |
| Jun 10, 2025 | 8-K | Current report | On SEC.gov |
| May 19, 2025 | 8-K | Current report | On SEC.gov |
| Apr 30, 2025 | 8-K | Current report | On SEC.gov |
| Apr 30, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Mar 12, 2025 | 8-K | Current report | On SEC.gov |
| Feb 19, 2025 | 8-K | Current report | On SEC.gov |
| Feb 19, 2025 | 10-K | Annual report | On SEC.gov |
| Dec 20, 2024 | 8-K | Current report | On SEC.gov |
| Nov 6, 2024 | 8-K | Current report | On SEC.gov |
| Nov 6, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Sep 12, 2024 | 8-K | Current report | On SEC.gov |
| Sep 9, 2024 | 8-K | Current report | On SEC.gov |
| Aug 1, 2024 | 8-K | Current report | On SEC.gov |
| Aug 1, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Jun 18, 2024 | 8-K | Current report | On SEC.gov |
| Jun 10, 2024 | 8-K | Current report | On SEC.gov |
| May 31, 2024 | 8-K | Current report | On SEC.gov |
| May 7, 2024 | 8-K | Current report | On SEC.gov |
| May 7, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Apr 8, 2024 | 8-K | Current report | On SEC.gov |
| Feb 29, 2024 | 8-K | Current report | On SEC.gov |
| Feb 21, 2024 | 8-K | Current report | On SEC.gov |
| Feb 21, 2024 | 10-K | Annual report | On SEC.gov |
| Jan 22, 2024 | 8-K | Current report | On SEC.gov |
| Dec 22, 2023 | 8-K | Current report | On SEC.gov |
| Dec 18, 2023 | 8-K | Current report | On SEC.gov |
| Dec 14, 2023 | 8-K | Current report | On SEC.gov |
| Nov 2, 2023 | 8-K | Current report | On SEC.gov |
| Nov 2, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Sep 27, 2023 | 8-K | Current report | On SEC.gov |
| Sep 26, 2023 | 8-K | Current report | On SEC.gov |
Figures describe Ionis Pharmaceuticals shares, not any token. As of Sep 23, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.